- Home
- CLNN vs PASG Comparison
CLNN vs PASG Comparison
Compare CLNN & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- PASG
- Stock Information
- Founded
- CLNN 2012
- PASG 2017
- Country
- CLNN United States
- PASG United States
- Employees
- CLNN N/A
- PASG N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- CLNN Health Care
- PASG Health Care
- Exchange
- CLNN Nasdaq
- PASG Nasdaq
- Market Cap
- CLNN 37.7M
- PASG 42.2M
- IPO Year
- CLNN N/A
- PASG 2020
- Fundamental
- Price
- CLNN $4.37
- PASG $0.39
- Analyst Decision
- CLNN Strong Buy
- PASG Strong Buy
- Analyst Count
- CLNN 4
- PASG 3
- Target Price
- CLNN $55.25
- PASG $7.67
- AVG Volume (30 Days)
- CLNN 42.3K
- PASG 163.2K
- Earning Date
- CLNN 05-07-2025
- PASG 03-04-2025
- Dividend Yield
- CLNN N/A
- PASG N/A
- EPS Growth
- CLNN N/A
- PASG N/A
- EPS
- CLNN N/A
- PASG N/A
- Revenue
- CLNN $421,000.00
- PASG N/A
- Revenue This Year
- CLNN N/A
- PASG N/A
- Revenue Next Year
- CLNN N/A
- PASG N/A
- P/E Ratio
- CLNN N/A
- PASG N/A
- Revenue Growth
- CLNN N/A
- PASG N/A
- 52 Week Low
- CLNN $3.82
- PASG $0.35
- 52 Week High
- CLNN $9.20
- PASG $1.69
- Technical
- Relative Strength Index (RSI)
- CLNN 45.51
- PASG 29.62
- Support Level
- CLNN $4.25
- PASG $0.39
- Resistance Level
- CLNN $4.60
- PASG $0.44
- Average True Range (ATR)
- CLNN 0.32
- PASG 0.06
- MACD
- CLNN 0.01
- PASG -0.01
- Stochastic Oscillator
- CLNN 46.67
- PASG 20.20
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.